21 Nov, 2024

Paxlovid antiviral therapy reduces risk of long COVID

In a current take a look at published to the medRxiv* server, researchers in Saint Louis, Missouri, tested whether or not nirmatrelvir remedy decreased the danger of lengthy COVID, the ailment encompassing the post-acute sequelae of intense acute respiration syndrome coronavirus 2 (SARS-CoV-2) [PASC]. Background The prevention of PASC is an pressing fitness priority, for […]

5 mins read